Aravax aims to safely revolutionise the lives of those with peanut allergy by removing the risk of life-threatening reactions to peanuts.

Aravax is an early stage biotechnology company focused on developing the first safe and rapidly effective treatment for peanut allergy. The treatment will use new technology that can reset the immune system to tolerate peanut without evoking allergic reactions during treatment.


Back to List